Livzon Pharmaceutical Group Inc. provided earnings guidance for the third quarter and nine months ending September 30, 2018. For the nine months, the company expected net profit attributable to the shareholders of the listed company in the range of RMB 877.2129 million to RMB 950.3704 million and basic earnings per share in the range of RMB 1.22 to RMB 1.33. The company expected net profit attributable to the shareholders of the listed company after deducting the extraordinary gain or loss in the range of RMB 795.0213 million to RMB 862.1901 million. For the quarter, the company expected net profit attributable to the shareholders of the listed company in the range of RMB 243.8586 million to RMB 317.0161 million and basic earnings per share in the range of RMB 0.34 to RMB 0.44. The company expected net profit attributable to the shareholders of the listed company after deducting the extraordinary gain or loss in the range of RMB 223.8961 million to RMB 291.0649 million.